Results 191 to 200 of about 145,768 (387)
One-electron oxidation and reduction of glycosaminoglycan chloramides: a kinetic study. [PDF]
A.W.J. Paterson+67 more
core +1 more source
Role of myeloperoxidase in the respiratory burst of human neutrophils [PDF]
WM Nauseef, JA Metcalf, RK Root
openalex +1 more source
Markers of progression to heart failure (HF). Gal‐4, galectin‐4; GDF‐15, growth differentiation factor 15; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; ST2, suppression of tumorigenicity‐2. ABSTRACT Aims Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart ...
Anna Dieden+23 more
wiley +1 more source
Biosynthesis and processing of myeloperoxidase — A marker for myeloid cell differentiation [PDF]
William M. Nauseef+2 more
openalex +1 more source
Abstract This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice.
Giuseppe M.C. Rosano+20 more
wiley +1 more source
Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode [PDF]
Anthony J. Kettle+1 more
openalex +1 more source
Abstract A better understanding of additional mechanisms of heart failure (HF) progression may allow a different and more complete phenotyping of the disease and identification of novel therapeutic targets. Persistent latent myocardial inflammation/immune activation in HF may represent an attempt to restore tissue homeostasis in the failing heart ...
Gabriele Fragasso+20 more
wiley +1 more source
Myeloperoxidase as an effective inhibitor of hydroxyl radical production. Implications for the oxidative reactions of neutrophils. [PDF]
Christine C. Winterbourn
openalex +1 more source
Myeloperoxidase and anti-myeloperoxidase autoantibodies in renal inflammation [PDF]
openaire +1 more source
In this study, we isolated and investigated the protective effect of 1,7‐diphenyl‐(6E)‐6‐hepten‐3‐ol (DPHP) against ulcerative colitis. Our results demonstrate that DPHP administration effectively alleviates colitis symptoms, inhibits inflammation, and strengthens antioxidant defense mechanisms. A combination of network pharmacology analysis, molecular
Van‐Long Truong+2 more
wiley +1 more source